Overview
HIV medicine is the field of clinical practice and research devoted to the prevention, diagnosis, treatment, and long-term management of infection with the human immunodeficiency virus. Its therapeutic core is antiretroviral therapy, combinations of drugs that interrupt the viral replication cycle at different stages, suppress viral load to undetectable levels, preserve and restore immune function as reflected in CD4 cell counts, and prevent progression to acquired immunodeficiency syndrome. Effective therapy also reduces transmission, linking individual treatment to public health benefit. Beyond drug regimens, HIV medicine encompasses prevention strategies such as pre-exposure prophylaxis and screening, the management of co-infections and comorbidities including osteoporosis, cardiovascular and ischemic heart disease, peripheral neuropathy, cognitive changes with aging, and opportunistic infections, and attention to adverse drug reactions and their associated costs. A central and recurring theme is adherence: sustained, consistent medication use is essential for durable viral suppression and to limit drug resistance, and research examines the psychosocial factors, healthcare-worker knowledge and attitudes, and monitoring approaches that support it across diverse and resource-limited settings. The discipline also addresses the social, behavioral, and structural dimensions of living with HIV, including barriers to care and implementation of services. By integrating pharmacologic treatment, prevention, and holistic patient management, HIV medicine has transformed HIV into a manageable chronic condition while continuing to confront resistance, comorbidity, and equitable access.
Research published in this journal
10 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Evaluation of Direct Cost of Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus Positive Patients
Knowledge, Attitude and Practice of Healthcare Workers Towards Availability of Antiretroviral Pre-Exposure Prohylaxis in Nigeria
The Prevalence of Osteoporosis in Hiv Infected Patient and its Correlation with Cd4 Count/Clinical Staging in Indian Population
Barriers and Opportunities to Improve the Implementation of Patient Screening and Linkage to Pre-Exposure Prophylaxis in Primary Care
Review of Useful Theories for Working with People Who are Living with HIV and AIDS
Physical Activity and Risk Factors Screening for Ischaemic Heart Disease in South African Individuals Living with HIV
When and How Should we be Measuring Adherence to Antiretroviral Therapy in Resource-Limited Settings?
Correlation of Cryptococcal Antigen Assay with C-reactive Protein as Serum and Urine Biomarker in Cryptococcal Meningitis: Experience in a Tertiary Hospital
How this research is being cited
The 10 articles above have been cited 36 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Discover Public Health
-
2026 · PLOS One
-
2026 · AIDS and Behavior
-
Knowledge, attitude, and practice regarding HIV pre-exposure prophylaxis (PrEP): a systematic review2025 · Journal of HIV/AIDS & Social Services
-
2025 · AIDS Patient Care and STDs
-
2025 · medRxiv (Cold Spring Harbor Laboratory)
-
2025 · AIDS Patient Care and STDs
-
2025 · Virology Journal
A sample of recent works citing this journal's research on Hiv Medicine, linking to each citing work.